Position in NVS
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$253,572
+$36,847 QoQ
Shares Held
1,618
-4.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#1,212
of 1,603 holders
Holding Since
Dec 2023
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TRITONPOINT WEALTH, LLC holds $34,735,241 across 9 Drug Manufacturers - General names. NVS ranks #9 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
67,646 | $17,180,054 | |
| 2 | MRK |
Merck & Co., Inc.
|
58,703 | $7,543,335 | |
| 3 | LLY |
ELI LILLY & Co
|
3,728 | $4,471,475 | |
| 4 | ABBV |
AbbVie Inc.
|
10,503 | $2,642,974 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
21,570 | $1,242,863 | |
| 6 | PFE |
Pfizer Inc
|
28,412 | $684,160 | |
| 7 | AMGN |
Amgen Inc
|
1,266 | $458,443 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
2,045 | $258,365 |
All Filings in NVS
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $253,572 | 1,618 | Shares | Sole | 2026-08-11 | |
| 2025-09-30 | $216,725 | 1,690 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $202,570 | 1,674 | Shares | Sole | 2025-07-17 | |
| 2024-03-31 | $208,646 | 2,157 | Shares | Sole | 2024-04-25 | |
| 2023-12-31 | $290,490 | 2,877 | Shares | Sole | 2024-01-24 | |
| No filing history on record for this holder in this stock. | ||||||